더바이오 10월 21일 주요뉴스 [https://www.thebionews.net/edit/webzine.html?idxno=667](https://www.thebionews.net/edit/webzine.html?idxno=667) ●[ESMO] 글로벌 항암신약 무대 오른 K바이오…암백신·ADC 3상에 쏠린 눈 [https://www.thebionews.net/news/articleView.html?idxno=29251](https://www.thebionews.net/news/articleView.html?idxno=29251) ●국내 바이오 IPO, 상반기 부진 딛고 하반기 ‘기지개’…7곳 예심 통과 [https://www.thebionews.net/news/articleView.html?idxno=29248](https://www.thebionews.net/news/articleView.html?idxno=29248) ●로슈·中한소 'ADC 플랫폼 동맹'…리가켐이 먼저 넓혀온 기술수출 모델 재조명 [https://www.thebionews.net/news/articleView.html?idxno=29254](https://www.thebionews.net/news/articleView.html?idxno=29254) ●루닛·뉴로핏, 신약 개발 현장서 ‘존재감’…임상 근거 쌓아 ‘매출 확대’ 노린다 [https://www.thebionews.net/news/articleView.html?idxno=29250](https://www.thebionews.net/news/articleView.html?idxno=29250) ●삼성바이오로직스, 3분기 매출 1조4903억원…연간 성장률 전망 상향(종합) [https://www.thebionews.net/news/articleView.html?idxno=29288](https://www.thebionews.net/news/articleView.html?idxno=29288) ●콜마바이오텍 주도 ‘바이오원 인피니티’ 출범…“R&D부터 사업화 연결” [https://www.thebionews.net/news/articleView.html?idxno=29279](https://www.thebionews.net/news/articleView.html?idxno=29279) ●LG화학, AI로 신약 찾고 환자 고른다…손지웅 사장 “경쟁력 결정짓는 핵심 엔진” [https://www.thebionews.net/news/articleView.html?idxno=29263](https://www.thebionews.net/news/articleView.html?idxno=29263) ●GSK ‘힙사고’, 만성 B형간염 美 FDA 승인…6개월 치료 완치율 19% [https://www.thebionews.net/news/articleView.html?idxno=29283](https://www.thebionews.net/news/articleView.html?idxno=29283) ●GSK ‘젬퍼리’, 직장암 첫 면역항암제 등극…美 FDA 신속 승인 [https://www.thebionews.net/news/articleView.html?idxno=29280](https://www.thebionews.net/news/articleView.html?idxno=29280) ●美 레볼루션 ‘졸돈라십’, RAS G12D 변이 폐암 1차치료 글로벌 3상 투약 개시 [https://www.thebionews.net/news/articleView.html?idxno=29278](https://www.thebionews.net/news/articleView.html?idxno=29278) ●사노피·테바 ‘TL1A 항체’, 염증성 장질환 2b상서 44주 효과 유지 [https://www.thebionews.net/news/articleView.html?idxno=29274](https://www.thebionews.net/news/articleView.html?idxno=29274) ●노보 ‘카그리세마’, 3상 사후분석서 여성 체중 25%↓…폐경 단계별 효과 관찰 [https://www.thebionews.net/news/articleView.html?idxno=29272](https://www.thebionews.net/news/articleView.html?idxno=29272) ●이승주 오름테라퓨틱 대표, 자사주 1만주 장내매수…1억7000만원 규모 [https://www.thebionews.net/news/articleView.html?idxno=29286](https://www.thebionews.net/news/articleView.html?idxno=29286) ●삼성바이오에피스, 1호 신약 후보물질 ‘SBE303’ 美 FDA 패스트트랙 지정 [https://www.thebionews.net/news/articleView.html?idxno=29259](https://www.thebionews.net/news/articleView.html?idxno=29259) ●셀트리온, 유럽 약국 채널 확대…고수익 제품군 4분기 판매 속도 [https://www.thebionews.net/news/articleView.html?idxno=29264](https://www.thebionews.net/news/articleView.html?idxno=29264) ●中 리즈 “PD-L1·4-1BB ‘오팜티스토미그’, 위암 1차 치료 2상 확장 진입” [https://www.thebionews.net/news/articleView.html?idxno=29253](https://www.thebionews.net/news/articleView.html?idxno=29253) ●알테오젠, ESG 평가기관 에코바디스 ‘골드 메달’…전세계 상위 4% 진입 [https://www.thebionews.net/news/articleView.html?idxno=29273](https://www.thebionews.net/news/articleView.html?idxno=29273) ●린버크, 원형탈모증·비분절 백반증 성인∙청소년 환자 치료 국내 허가 [https://www.thebionews.net/news/articleView.html?idxno=29275](https://www.thebionews.net/news/articleView.html?idxno=29275) ●오스템임플란트, 1200억원 규모 영구채 발행…“재무건전성 강화” [https://www.thebionews.net/news/articleView.html?idxno=29282](https://www.thebionews.net/news/articleView.html?idxno=29282) ●이노보테라퓨틱스, 코스닥 상장 증권신고서 제출…공모 절차 돌입 [https://www.thebionews.net/news/articleView.html?idxno=29284](https://www.thebionews.net/news/articleView.html?idxno=29284) ●Huons Announces Poster Presentation on Preclinical Results of 'Fibrostenotic Crohn’s Disease Treatment' at the UEG Week 2026 [https://www.thebionews.net/news/articleView.html?idxno=29249](https://www.thebionews.net/news/articleView.html?idxno=29249) ●[Interview] SkyLabs takes ring-type blood pressure monitor to U.S. FDA – "De Novo approval in 2027, commercialization in 2028" [https://www.thebionews.net/news/articleView.html?idxno=29245](https://www.thebionews.net/news/articleView.html?idxno=29245) ●LivsMed CEO Lee Jung-joo: “‘STARK,’ built on 90° multi-joint technology, to take on surgical robot market” [https://www.thebionews.net/news/articleView.html?idxno=29244](https://www.thebionews.net/news/articleView.html?idxno=29244) *제약바이오 10월 21일 아침 유튜브 라디오 뉴스(매일 아침 업로드) [https://www.youtube.com/watch?v=mS_RgeYUp7k](https://www.youtube.com/watch?v=mS_RgeYUp7k)